Science Explorer Back to mapMap
Discussion
Research facility · Bucharest · Romania

Institutul Oncologic Bucuresti

In research, Institutul Oncologic Bucuresti stands highest in Medicine (#4,729 of 8,541 worldwide) and Health Sciences (#5,727 of 9,902 worldwide), 2022-now.

iob.roROR OpenAlex
World rank, 2022-now
#20,551
of 22,385 · #29,524 all time
Rank in Romania
#113
of 126
Research works
364
▲ 27% vs 2018-21
Citations
3.6k
9.8 per fractional work
Top-10% rate
14.4%
all institutions 10.0%
vs its own fields
1.05×
1.00× is exactly expected
Open access
53%
world 40%
International
11%
world 18%
Institutul Oncologic Bucuresti

What is Institutul Oncologic Bucuresti known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #4,729 of 8,541 16.0%70 #10556
Health SciencesDomain #5,727 of 9,902 16.1%70 #12206

Each strip is that field's whole ranked pool, with the notch where Institutul Oncologic Bucuresti sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Institutul Oncologic Bucuresti work in?

In 2022-now, 76% of research at Institutul Oncologic Bucuresti is in Health Sciences, 14% in Life Sciences. Its largest fields are Medicine (76%), Biochemistry, Genetics and Molecular Biology (10%), Arts and Humanities (3%). It does 3.0× the world's share of Health Sciences.

Health Sciences: 77 fractional works · 75.9% of its workMedicine: 76 fractional works · 75.5% of its workOncology: 17 fractional works · 17.2% of its workPulmonary and Respiratory Medicine: 13 fractional works · 13.0% of its workSurgery: 11 fractional works · 11.0% of its workEpidemiology: 4 fractional works · 4.4% of its workRadiology, Nuclear Medicine and Imaging: 4 fractional works · 3.7% of its workObstetrics and Gynecology: 4 fractional works · 3.6% of its workReproductive Medicine: 3 fractional works · 3.3% of its workPathology and Forensic Medicine: 3 fractional works · 2.9% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 1.7% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 1.5% of its workNeurology: 1 fractional works · 1.2% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.1% of its workGastroenterology: 1 fractional works · 1.1% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.0% of its workOphthalmology: 1 fractional works · 0.9% of its workRheumatology: 1 fractional works · 0.9% of its workInfectious Diseases: 1 fractional works · 0.8% of its workGenetics: 1 fractional works · 0.8% of its workHepatology: 1 fractional works · 0.7% of its workHealth Informatics: 1 fractional works · 0.6% of its workPsychiatry and Mental health: 1 fractional works · 0.5% of its workDermatology: 1 fractional works · 0.5% of its workAnatomy: 0 fractional works · 0.5% of its workEmergency Medicine: 0 fractional works · 0.4% of its workPhysiology: 0 fractional works · 0.4% of its workNephrology: 0 fractional works · 0.4% of its workHematology: 0 fractional works · 0.3% of its workOtorhinolaryngology: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.8% of its workDentistry: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 0.1% of its workLife Sciences: 14 fractional works · 13.7% of its workBiochemistry, Genetics and Molecular Biology: 10 fractional works · 9.6% of its workMolecular Biology: 4 fractional works · 4.4% of its workCancer Research: 3 fractional works · 3.1% of its workGenetics: 1 fractional works · 1.4% of its workMolecular Medicine: 0 fractional works · 0.2% of its workClinical Biochemistry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 2 fractional works · 2.4% of its workImmunology: 2 fractional works · 2.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 1 fractional works · 1.1% of its workCognitive Neuroscience: 0 fractional works · 0.3% of its workDevelopmental Neuroscience: 0 fractional works · 0.3% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.2% of its workSocial Sciences: 7 fractional works · 6.5% of its workArts and Humanities: 3 fractional works · 3.0% of its workLanguage and Linguistics: 2 fractional works · 2.3% of its workLiterature and Literary Theory: 1 fractional works · 0.7% of its workSocial Sciences: 2 fractional works · 2.1% of its workSociology and Political Science: 1 fractional works · 1.0% of its workEducation: 0 fractional works · 0.3% of its workLaw: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workPsychology: 1 fractional works · 0.8% of its workExperimental and Cognitive Psychology: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workBusiness, Management and Accounting: 0 fractional works · 0.5% of its workMarketing: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workDecision Sciences: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.0% of its workPhysical Sciences: 4 fractional works · 3.8% of its workComputer Science: 1 fractional works · 1.4% of its workArtificial Intelligence: 1 fractional works · 0.6% of its workComputational Theory and Mathematics: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workEngineering: 1 fractional works · 0.9% of its workBiomedical Engineering: 1 fractional works · 0.9% of its workEnvironmental Science: 1 fractional works · 0.7% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 0.3% of its workRadiation: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 0.3% of its workBiomaterials: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 0 fractional works · 0.2% of its workALL ITS WORKInstitutulOncologic…101fractional works, 2022-now
Life Sciences14%Physical Sciences4%Health Sciences76%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine7675.5%
    2. Dentistry00.3%
    3. Health Professions00.1%
    1. Biochemistry, Genetics and Molecular Biology109.6%
    2. Immunology and Microbiology22.4%
    3. Neuroscience11.1%
    4. Agricultural and Biological Sciences00.3%
    5. Pharmacology, Toxicology and Pharmaceutics00.2%
    1. Arts and Humanities33.0%
    2. Social Sciences22.1%
    3. Psychology10.8%
    4. Business, Management and Accounting00.5%
    5. Decision Sciences00.1%
    6. Economics, Econometrics and Finance00.0%
    1. Computer Science11.4%
    2. Engineering10.9%
    3. Environmental Science10.7%
    4. Physics and Astronomy00.3%
    5. Materials Science00.3%
    6. Chemistry00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.07× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.80× its world share, 10 worksBiochemistry, Geneti…Immunology and Microbiology: 2.42× its world share, 2 worksImmunology and Micro…Neuroscience: 0.68× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.55× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.11× its world share, 0 worksChemistryComputer Science: 0.18× its world share, 1 worksComputer ScienceEngineering: 0.06× its world share, 1 worksEngineeringEnvironmental Science: 0.14× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.09× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.15× its world share, 0 worksPhysics and AstronomyDentistry: 0.57× its world share, 0 worksDentistryHealth Professions: 0.05× its world share, 0 worksHealth ProfessionsMedicine: 3.93× its world share, 76 worksMedicineArts and Humanities: 1.03× its world share, 3 worksArts and HumanitiesBusiness, Management and Accounting: 0.15× its world share, 0 worksBusiness, Management…Decision Sciences: 0.13× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.02× its world share, 0 worksEconomics, Econometr…Psychology: 0.28× its world share, 1 worksPsychologySocial Sciences: 0.17× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.9×. Every wedge is a field page.

All 20 fields, with their numbers
  1. Medicine3.93×76 works
  2. Immunology and Microbiology2.42×2 works
  3. Biochemistry, Genetics and Molecular Biology1.80×10 works
  4. Arts and Humanities1.03×3 works
  5. Neuroscience0.68×1 works
  6. Dentistry0.57×0 works
  7. Pharmacology, Toxicology and Pharmaceutics0.55×0 works
  8. Psychology0.28×1 works
  9. Computer Science0.18×1 works
  10. Social Sciences0.17×2 works
  11. Physics and Astronomy0.15×0 works
  12. Business, Management and Accounting0.15×0 works
  13. Environmental Science0.14×1 works
  14. Decision Sciences0.13×0 works
  15. Chemistry0.11×0 works
  16. Materials Science0.09×0 works
  17. Agricultural and Biological Sciences0.07×0 works
  18. Engineering0.06×1 works
  19. Health Professions0.05×0 works
  20. Economics, Econometrics and Finance0.02×0 works

Who are the top researchers at Institutul Oncologic Bucuresti?

Ranked on the quality score, Aurelia Alexandru, Elena Chitoran and Mircea Dediu lead among researchers whose main affiliation is Institutul Oncologic Bucuresti.

  1. 1 Aurelia Alexandru Romania · #267,734 worldwide 10k citations · 57 works
  2. 2 Elena Chitoran Romania · #860,089 worldwide 345 citations · 53 works
  3. 3 Mircea Dediu Romania · #1,216,314 worldwide 12k citations · 90 works
  4. 4 Monica Desiree Dragomir Romania · #1,447,982 worldwide 907 citations · 31 works
  5. 5 Ciprian Cirimbei Romania · #2,397,596 worldwide 295 citations · 64 works
  6. 6 Vlad Rotaru Romania · #2,519,644 worldwide 269 citations · 31 works
  7. 7 Adelina Silvana Gheorghe Romania · #3,357,123 worldwide 265 citations · 37 works
  8. 8 Valentina Negoiţă Romania · #3,545,376 worldwide 164 citations · 17 works
  9. 9 M. Chirita Romania · #3,874,158 worldwide 15 citations · 20 works
  10. 10 L. N. Minea Romania · #3,930,663 worldwide 23 citations · 15 works
All ranked researchers at Institutul Oncologic Bucuresti

What are the most cited papers from Institutul Oncologic Bucuresti?

The most cited paper from Institutul Oncologic Bucuresti is "Erlotinib in Previously Treated Non–Small-Cell Lung Cancer" (Frances Alice Shepherd, José Rodrigues Pereira, Tudor–Eliade Ciuleanu et al., 2005), with 5,471 citations. Next come "Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer" (2,901) and "First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial" (1,396).

Most cited papers
#PaperReleasedCitations
1 Erlotinib in Previously Treated Non–Small-Cell Lung Cancer Frances Alice Shepherd, José Rodrigues Pereira, Tudor–Eliade Ciuleanu et al. · New England Journal of Medicine Open access 13 Jul 2005 5,471
2 Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer Matthew David Hellmann et al. · New England Journal of Medicine Open access 28 Sep 2019 2,901
3 First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial Luis G Paz-Ares et al. · The Lancet Oncology 18 Jan 2021 1,396
4 miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis Carmen Elena Condrat, Dana Claudia Thompson, Mădălina Gabriela Barbu et al. · Cells Open access 23 Jan 2020 1,367
5 Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial Edward B. Garon et al. · The Lancet Open access 2 Jun 2014 1,321
All 60 most cited papers, with filters and sorting

Which keywords describe research at Institutul Oncologic Bucuresti?

By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Immunotherapy, Survival Analysis, Radiotherapy, Metastasis, Neoadjuvant Therapy and Clinical Trials.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy14▲ 19×21 topics
  2. Clinical Practice Guidelines9▲ 16×10 topics
  3. Immunotherapy8▲ 11×15 topics
  4. Survival Analysis8▲ 28×6 topics
  5. Epidemiology7▲ 1.76×33 topics
  6. Radiotherapy7▲ 18×11 topics
  7. Metastasis7▲ 20×10 topics
  8. Clinical Trials6▲ 8.1×8 topics
  9. Neoadjuvant Therapy6▲ 23×5 topics
  10. Quality of Life5▲ 3.6×14 topics
  11. Tumor Microenvironment5▲ 11×6 topics
  12. Cervical Cancer5▲ 46×3 topics
  13. Cancer5▲ 3.6×21 topics
  14. Biomarkers5▲ 6.5×6 topics
  15. Prognostic Factors4▲ 10×10 topics
  16. Sentinel Lymph Node Biopsy4▲ 50×2 topics
  17. Breast Cancer4▲ 17×9 topics
  18. Molecular Classification4▲ 28×4 topics
  19. Radiation Therapy4▲ 31×5 topics
  20. Precision Medicine4▲ 7.6×5 topics
  21. Robotic Surgery4▲ 24×3 topics
  22. Prognostic Markers4▲ 32×3 topics
  23. Brachytherapy3▲ 78×1 topic
  24. Cancer Incidence3▲ 24×4 topics
  25. Cytoreductive Surgery3▲ 50×2 topics
  26. Endometrial Carcinoma3▲ 78×1 topic
  27. Ovarian Cancer3▲ 36×2 topics
  28. Molecular Profiling3▲ 33×3 topics
  29. Tumor Staging3▲ 27×2 topics
  30. Genetic Mutations3▲ 6.9×8 topics
  31. Genomic Analysis3▲ 11×2 topics
  32. Adjuvant Chemotherapy3▲ 41×2 topics
  33. Mutation Analysis3▲ 37×1 topic
  34. Tumor Models3▲ 47×1 topic
  35. Adjuvant Therapy3▲ 21×2 topics
  36. Immunohistochemistry3▲ 38×3 topics
  37. Molecular Characterization3▲ 15×4 topics
  38. Tumor Markers3▲ 32×2 topics
  39. Molecular Subtypes2▲ 28×2 topics
  40. Targeted Therapy2▲ 11×4 topics

Which research topics does Institutul Oncologic Bucuresti publish most on?

By volume in 2022-now: Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Lung Cancer Diagnosis and Treatment and Cancer Immunotherapy and Biomarkers.

Endometrial and Cervical Cancer Treatments: 3 fractional worksOvarian cancer diagnosis and treatment: 3 fractional worksLung Cancer Diagnosis an…2Lung Cancer Diagnosis and Treatment: 2 fractional worksCancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksColorectal Cancer Surgical Treatments: 2 fractional worksCervical Cancer and HPV Research: 2 fractional worksRadiomics and Machine Le…2Radiomics and Machine Learning in Medical Imaging: 2 fractional worksBreast Cancer Treatment Studies: 1 fractional worksCancer Treatment and Pharmacology: 1 fractional worksMetastasis and carcinoma…1Metastasis and carcinoma case studies: 1 fractional works
Obstetrics and GynecologyReproductive MedicinePulmonary and Respiratory MedicineOncology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 3 works
  2. 2 Ovarian cancer diagnosis and treatment Reproductive Medicine 3 works
  3. 3 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 2 works
  5. 5 Colorectal Cancer Surgical Treatments Oncology 2 works
  6. 6 Cervical Cancer and HPV Research Epidemiology 2 works
  7. 7 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 2 works
  8. 8 Breast Cancer Treatment Studies Cancer Research 1 works
  9. 9 Cancer Treatment and Pharmacology Oncology 1 works
  10. 10 Metastasis and carcinoma case studies Pulmonary and Respiratory Medicine 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.0%not open47.0%

World: 40% of research is openly available.

with international co-authors11.3%domestic only88.7%

World: 18% is written across borders.

How has Institutul Oncologic Bucuresti's research output changed?

Output in 2022-2025 was 27% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Institutul Oncologic Bucuresti as a percentage of every work published that year, 0.00042% in 2024.

still counting0.00050%0.0010%0.0015%Institutul Oncologic Bucuresti0.00043% in 202519801990200020102020

Fractional works of Institutul Oncologic Bucuresti over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting10%20%Institutul Oncologic Bucuresti17.7% in 2025all institutions10.0% in 20252020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 17.7% in 2025.

Other research institutions in Bucharest

All research institutions in Bucharest

Share Institutul Oncologic Bucuresti's ranking

Institutul Oncologic Bucuresti on Science Explorer

A card with Institutul Oncologic Bucuresti's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Institutul Oncologic Bucuresti. Posts are plain text and can be reported.